ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard J. Williams
Timothy B. Icenogle
Jack G. Copeland
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saigenji, H.
Right arrow Articles by Copeland, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saigenji, H.
Right arrow Articles by Copeland, J. G.

Ann Thorac Surg 1991;52:107-111
© 1991 The Society of Thoracic Surgeons

Articles

Pneumocystis carinii pneumonia after heart transplantation

Hideaki Saigenji, MD1, Mitsunori Kaneko, MD, Birger Rhenmen, MD, Richard J. Williams, MD, M.Andre Vasu, MD, Timothy B. Icenogle, MD, Jack G. Copeland, MD*

Section of Cardiovascular and Thoracic Surgery, Department of Surgery, University of Arizona, Tucson, Arizona USA

Accepted for publication March 20, 1991.

* Address reprint requests to Dr Copeland, Section of Cardiovascular and Thoracic Surgery, University of Arizona Health Sciences Center, 1501 N Campbell Ave, Tucson, AZ 85724.

Five patients with Pneumocystis carinii pneumonia after heart transplantation are reported. Four had severe clinical symptoms, whereas 1 was asymptomatic. Mechanical ventilatory support was necessary in 1 because of respiratory distress. Pneumocystis carinii infection developed in 4 patients within the first 4 postoperative months, and 1 patient had clinical disease 1 year after transplantation with a recurrence 9 months later. All were treated with trimethoprim-sulfamethoxazole either orally or intravenously (10 to 20 mg · kg–1 · day–1 of trimethoprim). All patients recovered from infection and received the same drug prophylactically for 2 to 20 months after the infection. All patients are doing well after Pneumocystis carinii infection except 1 who died after an acute myocardial infarction 4 years after infection. We conclude that trimethoprim-sulfamethoxazole is an effective agent for the treatment of Pneumocystis carinii pneumonia after heart transplantation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The Society of Thoracic Surgeons.